While recent works have focused on the immunomodulatory and immunosuppressive consequences of CEACAM-1 engagement by Fn in T and NK cells, the data presented here underscore the relevance of this pathogenic interaction on the cancer cell side. The gene discussed is CEACAM1; the disease is cancer.